Center For Technology Licensing

CTL Life Sciences November Office Hours With Marie Donnelly
2024-11-19 14:00 - 16:00 UTC | 115 Stocking Hall, 411 Tower Rd, Ithaca, NY, 14853, United States
Every month, CTL Business Development and Licensing Associates will be available to meet in person during office hours open to all who wish to get an answer to their intellectual property questions, gain more information about the advancement of their IP filings, or learn about technology venture creation with a one-on-one meeting.
Our next office hours will take place on Tuesday, November 19, at Vet Research Tower: VRT T3004A Conf Rm, hosted by Marie Donnelly, a CTL Business Development and Licensing Associate, who will be available every 3rd Tuesday of each month.
Marie has a Ph.D. in Biological and Environmental Sciences from Cornell and is an excellent resource for your licensing, IP, startup, and gap funding opportunities. She specializes in applied microbiology, agriculture, and bioengineering.
During the office hours, Marie will be available for 30-minute in-person sessions. To reserve your spot, please click on the registration button below and select your preferred time. We encourage all individuals who are interested in gaining more information about intellectual property or technology venture creation to attend.
Save your one-on-one spot here.

Lab to Impact: Commercialization and Venture Module on Founder's Equity
2024-11-20 12:00 - 13:00 (America/New_York)
Join the Cornell Center for Technology Licensing leadership for the Lab to Impact series, where we focus on intellectual property and guide you through the essential steps of the technology commercialization process. You will gain insights into the end-to-end process, from initial invention disclosure to IP protection, licensing, and, ultimately, commercialization.
Join Nabil Ullah, Senior Investment Analyst at Osage University Partners (OUP), for an in-depth workshop on Founder’s Equity, tailored for new founders navigating equity allocation among co-founders, advisors, and early employees. This interactive session delves into venture capital perspectives on university startup formation, covering essential topics like timing and strategies for equity distribution, determining equity splits, and understanding the potential impacts of poor allocation choices. We recommend attendees read OUP’s Solving the Equity Equation before the session.

CTL Life Sciences November Office Hours With Sarah Ward
2024-11-20 13:00 - 15:00 UTC | Center for Life Science Ventures, 237 Tower Rd, Ithaca, NY, 14850, United States
Every month, CTL Business Development and Licensing Associates will be available to meet in person during office hours open to all who wish to get an answer to their intellectual property questions, gain more information about the advancement of their IP filings, or learn about technology venture creation with a one-on-one meeting.
Our next office hours will take place on Wednesday, November 20, at Weill Hall 221 hosted by Sarah Ward, a CTL Business Development and Licensing Associate, who will be available every 3rd Wednesday of each month.
Sarah has a Ph.D. in Polymer Science and Engineering and is an excellent resource for your licensing, IP, startup, and gap funding opportunities. She specializes in polymer/organic chemistry and materials science.
During the office hours, Sarah will be available for 30-minute in-person sessions. To reserve your spot, please click on the registration button below and select your preferred time. We encourage all individuals who are interested in gaining more information about intellectual property or technology venture creation to attend.
Save your one-on-one spot here.

Ignite Fellow for New Ventures Information Session
2024-12-04 12:00 - 13:00 (America/New_York) | Online Webinar
One of the four signature programs of Ignite Cornell Research Lab to Market gap fund series. Launched in 2022, Ignite Fellow for New Ventures program funds and trains Ph.D. and master’s holders with entrepreneurial outlooks to start technology ventures.
The program aims to build new solid businesses, grow entrepreneur scientists and engineers, advance technology commercialization, and enrich Cornell’s venture ecosystem by creating high-value startup companies based on the partnership of an Ignite candidate and faculty inventor.
Join this information session to learn more.

Weill Cornell Medicine Symposium on Innovation and Entrepreneurship
2024-12-18 12:00 - 17:45 (America/New_York)
Weill Cornell Medicine’s free Symposium on Innovation and Entrepreneurship welcomes Cornell’s life sciences community to explore the power of innovation in medicine and biotechnology.
This event will feature engaging faculty panels; remarks from Cornell’s Vice President for Research and Innovation, Krystyn J. Van Vliet, Ph.D.; and a fireside chat hosted by Dr. Robert A. Harrington, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, with Rachel Haurwitz, Ph.D., President and CEO of Caribou Biosciences.
Registrants can attend the event in person in New York City, and a Zoom link will be sent to Ithaca-based registrants the day of the event.
View the full event schedule and register here: https://deanssymposium.eventbrite.com/

Ignite Fellow for New Ventures Information Session #3
2025-01-10 12:00 - 13:00 (America/New_York) | Online Webinar

Lab to Impact: How a Supreme Court Ruling Impacts Patents
2025-01-23 12:00 - 13:00 (America/New_York) | Online Webinar
Are you an inventor or entrepreneur that has patent applications? The rules of the game just changed.

A recent Supreme Court ruling has put a spotlight on the enablement requirement—a critical, but often overlooked, aspect of patenting. What is the enablement requirement? It is the need for patents to clearly and fully explain how to make and use the invention, ensuring the claims are understandable and replicable by others in the field.

Now, patents must fully explain the scope of their claims and innovators with CTL must adjust their strategies accordingly.

Join us for an insightful webinar with Yvonne Shyntum, Partner at Pabst Patent Group, where you’ll gain practical insights into the ruling and how to stay ahead in this evolving landscape.

What you’ll learn:

What the Supreme Court’s new interpretation of enablement means for your patents.
Practical strategies for crafting strong, compliant patent applications.
Insights from a seasoned expert in biotechnology and pharmaceutical patents.

About the speaker: Dr. Yvonne Shyntum is a leading IP attorney with extensive experience in the biotechnology and pharmaceutical sectors.
About the Host: Dr. Gene Masters directly with Cornell innovators in protecting their IP on behalf of Cornell and is a registered patent attorney with extensive expertise in patent filings in the life sciences innovation.

Don’t miss this learning opportunity on future-proof your patents (RSVP)

Ignite Connect 2025
2025-02-04 12:00 - 14:00 (America/New_York)
We are delighted to extend an invitation for the Ignite Connect: Accelerating Impact, one of the new signature events of the Ignite Cornell Lab to Market program series. This virtual event serves as a unique venue to connect investors, industry partners, and stakeholders with technology innovations and companies that have benefited from the Ignite Gap Funding Program.
Date: February 4, 2024
Time: Noon – 2:00 p.m.
Location: Online (Register here)
About the event:
Ignite Connect is an opportunity to explore and engage with researchers and founders around their technologies and ventures emerging from Cornell University.
This dynamic virtual experience aims to create connections and serves as a catalyst, bridging innovative technologies with resources and opportunities for meaningful impact.
Agenda Highlights:

12-12:10p: Welcome by Alice Li

12:10-12:30p: DeRisking Spotlight

12:30-1:30p: Pitch Sessions

1:30-3:00p: Networking

Find Your Track:
Therapeutics
MedTech
Energy and Environment
Engineering and Digital
Five to six technology or startup presentations per track. Visit our website for more details.

Ignite Fellows for New Venture Info Session #4
2025-02-12 12:00 - 13:00 (America/New_York)
The Office of the Vice President for Research and Innovation (OVPRI) at Cornell University has launched the Ignite Postdoc for Ventures program–one of the four signature programs of Ignite Cornell Research Lab to Market gap fund series–in January 2022 to fund and train candidates with entrepreneurial outlooks to start technology ventures based on groundbreaking Cornell invention portfolios.
For this fourth annual recruitment, the program will accept master graduates, PhDs and candidates. The goal of the program is to build strong new businesses, grow entrepreneur scientists and engineers, advance technology commercialization, and enrich Cornell’s venture ecosystem by creating high-value startup companies based on the partnerships of an Ignite candidate and faculty inventor. With the strength of Cornell based on its founding principal “… any person … any study”, this program allows any aspiring entrepreneurs to find the right innovation among the broad range of great discoveries made in the lab and the diversifying body of faculty innovators. The program de-risks the entrepreneurship journey by providing a funding package of up to $120,000 which includes salary compensation of the fellow and funding to conduct basic experiments. As a Cornell employee, the fellow will be eligible to the benefits accessible to any Cornell employees.
We are looking for candidates who dream big and take risks, want to become a CEO, CSO, or CTO founder, and want to take their entrepreneurial skills to the next level.
Register for the info session here.

Lab to Impact Health Module: From Discovery to Diagnostics, Navigating Biomarker Commercialization
2025-02-19 12:00 - 13:00 (America/New_York)
Wednesday, February 19 | 12 – 1 p.m. ET | Virtual
Interested in understanding the journey from biomarker discovery to real-world healthcare applications? Researchers and innovators are invited to this insightful discussion on navigating the path from discovery to commercial success in the biomarker and diagnostics space.
Industry leaders and successful entrepreneurs will share practical insights on identifying commercially viable biomarkers, early-stage validation, test development, regulatory pathways, and integration into clinical practice. Whether you’re considering commercialization or actively developing diagnostic solutions, this panel offers valuable perspectives on turning promising research into market-ready products.
Moderated by Iris Bica, a Business Development and Licensing Associate for the Center of Technology Licensing at Weill Cornell Medicine, the panel will feature:

Dan Klass, Senior Director of Emerging Technologies, Freenome

Marieke Spaan, Senior Director Corporate Development, SkylineDx

Daniel Lunz, CEO & Co-Founder, Previse

RSVP here

Lab to Impact Health Module: Thought Leader Series at Cornell Tech
2025-03-10 18:00 - 21:00 (America/New_York) | Cornell Tech, New York City, 2 West Loop Road, New York, NY, 10044, United States
Monday, March 10 | 6- 9 p.m. ET | Tata Innovation Center, Cornell Tech
Unlocking the Future of Blockchain with Emin Gün Sirer
Join us for a dynamic in-person event at Cornell Tech as part of the Lab to Impact: Thought Leader Series – where visionaries share their insights into the future of innovation.
The Center for Technology Licensing at Cornell is thrilled to host Emin Gün Sirer, Founder and CEO of Ava Labs, for a fireside chat on the latest trends in blockchain technology and its transformative impact on the world. The conversation will be moderated by Martin Teschl, the Director of Business Development and Licensing for CTL.
The event will take place in the Tata Innovation Center, Room 123. The fireside chat will begin at 6:15 p.m. with a networking reception to follow at 7:30 p.m. Register for the event.

Translating Your Discoveries into a Powerful Preclinical Data Package
2025-03-25 12:00 - 13:30 (America/New_York)
Weill Cornell Medicine Enterprise Innovation will be hosting a virtual panel focused on the critical aspects of preclinical drug discovery. The panel will feature experienced biotech investors and industry scientists who will provide guidance on the key steps involved in de-risking a novel drug development idea. This program will be useful to Weill Cornell researchers interested in starting a drug discovery project or optimizing existing compounds for the purpose of attracting commercial partnership or investment interest.
What you’ll learn:

Criteria for choosing therapeutic target, drug modality, and clinical indication with significant unmet need
Key stages of drug discovery, including high throughput screening, hit finding strategies, and choosing a lead compound
Understanding the differences between small molecule and biologics discovery campaigns
Assessing the target product profile (TPP), including safety liabilities, efficacy benchmarks, dose finding, pharmacokinetics, and appropriate “therapeutic benchmarks”

Register for the virtual event.

Ignite Innovation Acceleration Information Session
2025-03-28 12:00 - 13:00 (America/New_York)
Ignite Innovation Acceleration provides grant funding to Cornell labs that are working to advance their innovations toward licensing, startup formation, or industry partnerships. The program is open to inventions disclosed to CTL from Ithaca, Geneva, or Cornell Tech.

Funding up to $50,000 is provided in the form of project-specific grants with no payback requirement.
Attend this information session to learn more about the opportunity. Register for the info session.

Weill Cornell Medicine Biomedical Innovation Conference
2025-04-01 15:00 - 18:00 (America/New_York) | Uris Auditorium, 1300 York Avenue, New York, 10065, United States
The 2025 Weill Cornell Medicine Biomedical Innovation Conference brings together academic founders with investors, industry representatives, entrepreneurs and ecosystem partners with the expressed goal of finding opportunities to connect and collaborate. The conference is a rare opportunity to meet a diverse group of life science inventors and spinout companies across therapeutics, device, digital health and diagnostic sectors. All Weill Cornell Medicine-affiliated inventors are encouraged to participate. In addition, select startup companies from the Upper East Side ecosystem, including Rockefeller University, Memorial Sloan Kettering, and surrounding hospitals, as well as startups where faculty serve as CMOs and Scientific Advisors, are also in attendance.
Over the years, this event has been a proven catalyst for direct investment from early-stage investors, co-development relationships with industry, and introductions to experienced management teams. Please contact Loren Busby (lob4002@med.cornell.edu) for more information.
Register for the event.

Lab to Impact: Medical Device Commercialization - A Journey from Breakthrough Research to Patient-Ready Technology
2025-04-08 13:00 - 14:00 (America/New_York)
Check out the recording for this event here.
Join the Center for Technology Licensing for a virtual session focused on medical device innovation and regulation.
Bringing groundbreaking medical devices from concept to patient care is no small feat. It requires a careful balance of scientific ingenuity, strategic development, and regulatory compliance. Join us for an exclusive panel discussion featuring top experts who have successfully navigated this complex landscape.
This session will provide invaluable insights into the journey from idea to market-ready medical technology, covering key aspects such as:

Navigating the FDA approval process

Balancing innovation with regulatory requirements

Strategies for successful device development

Emerging challenges in the medical device industry

Whether you’re considering a new idea, commercialization, or actively developing medical device solutions, this panel offers valuable perspectives on turning promising research into market-ready medical devices.
Meet the expert panelists:

Mark Melkerson – Former FDA Deputy Director, Office of Health Technology / CDRH / ODE; Principal, MNM Consulting

Thomas Roueche – President & CEO, Fesarius Therapeutics

Jason Spector, MD – Chief, Division of Plastic & Reconstructive Surgery, Weill Cornell Medicine; Co-Founder, Fesarius Therapeutics

Ignite Innovation Acceleration Information Session
2025-04-11 12:00 - 13:00 (America/New_York)
Ignite Innovation Acceleration provides grant funding to Cornell labs that are working to advance their innovations toward licensing, startup formation, or industry partnerships. The program is open to inventions disclosed to CTL from Ithaca, Geneva, or Cornell Tech.

Funding up to $50,000 is provided in the form of project-specific grants with no payback requirement.
Attend this information session to learn more about the opportunity. Register for the information session.

Seeking Entrepreneurs: Turning University Research into Tech Venture
2025-04-11 14:30 - 15:30 (America/New_York)
This panel is part of the Entrepreneurship at Cornell Celebration Ezra. Attendees must register for Celebration Ezra to attend this session.
Moderated by Alice Li, this session will spotlight Cornell faculty innovators who are actively seeking entrepreneurial partners, including potential CEOs, to bring their technologies to life. Join us for a lively discussion with three faculty founders, each navigating the journey from lab to launch. The panel will culminate in an open networking session, offering a unique opportunity to connect with fellow innovators, entrepreneurs, and returning Cornell alumni eager to engage with the next wave of university-born innovation. Whether you are an aspiring founder, experienced operator, or simply curious about the future of academic startups, this event promises insight, inspiration, and connection.
Panelists:

Christopher Alabi, Associate Professor, Smith School of Chemical and Biomolecular Engineering
Joseph Peters, Professor and Chair, Microbiology, CALS
Rong Yang, Assistant Professor, Smith School of Chemical and Biomolecular Engineering

Moderated by Alice Li MS ’95, PhD ’98, Executive Director, Center for Technology Licensing at Cornell University (CTL)

Inspiring Futures - Facilitated Mixer
2025-04-11 15:30 - 17:00 (America/New_York)
This event is part of the larger Entrepreneurship at Cornell Celebration Ezra. To attend this session, attendees must register for Celebration Ezra.
Inspirational Spotlight: Professor Hakim Weatherspoon, Professor of Computer Science and Associate Dean for Diversity, Equity, and Inclusion for the Cornell Ann S. Bowers College of Computing and Information Science.
Inspiring Futures is an engaging event designed to connect and empower, especially historically underrepresented individuals who have faced barriers in entering the field and/or in securing funding. We will spotlight first-time founders at Cornell, their technologies, or their startups. Through a curated selection of games, discussion, and display of posters, attendees will immerse themselves in the stories of Cornell innovators and entrepreneurs and discover methods to support and move forward in the modern entrepreneurial landscape.
Entrepreneurship should be accessible to everyone, and we aim to foster a community of support and encouragement, where every participant can see the potential for their own story. This reception is a call to action for all entrepreneurs, or entrepreneurs to be, to share, learn from each other, break down barriers, and build a more inclusive and equitable entrepreneurial ecosystem.
“Inspiring Futures” reception is your opportunity to contribute to and connect with like-minded individuals, learn about success stories, share challenges, and empower your entrepreneurial journey.
Organized by the Center for Technology Licensing and Computer Information Sciences. Supported by contributions from CTL, CIS, and the Engineering Career Center.

WCM Office Hours with Eric Bryant
2025-04-15 14:00 - 16:00 (America/New_York)
Eric holds a Master of Science in Biomedical Engineering from New York University (NYU), a Juris Doctor from New York Law School, and is a registered patent attorney. He works with the Weill Cornell office to execute on intellectual property strategy, review submitted invention disclosures, and manage domestic and foreign patent filings and patent prosecution. Eric’s expertise encompasses a variety of technologies including, but not limited to, diagnostics tools and methods, pharmaceuticals, controlled release therapeutic devices, respiratory devices, surgical tools, biological technologies and nanotechnology.
To reserve your 30-minute Zoom office hours session, click on the registration button below and select your preferred time. You will be given access to a Zoom registration link and will meet privately with Eric within that Zoom session.
Book with Eric on April 15 from 2-4 p.m. on Zoom.

WCM Office Hours with Louise Sarup
2025-04-17 14:00 - 16:00 (America/New_York)
Louise manages a portfolio of medical technologies focusing on imaging, platform technologies, and algorithms. She is a seasoned professional with years of experience in licensing and commercialization and is eager to answer your questions and provide valuable insights.
To reserve your 30-minute Zoom office hours session, click on the registration button below and select your preferred time. You will be given access to a Zoom registration link and will meet privately with Louise within that Zoom session.
Book with Louise on April 17 from 2 -4 p.m. at the NYC Office

Venturium '25 - Academic Venture Showcase
2025-04-23 11:30 - 14:30 (America/New_York)
Venturium’25 is a virtual, half-day showcase for spinouts from several academic institutions across the USA. The selected companies are actively raising a pre-seed or seed round to drive development and commercialization.
​Why Attend? This one-of-a-kind event allows our audience of venture capital, venture studios, accelerators, incubators, and industry to explore a curation of companies and innovation technologies.
​Attend to meet academic spinouts from Cornell University, Kentucky Commercialization Ventures, Northeastern University, Rutgers University, University of Connecticut, University of Louisville, University of Pennsylvania, and Washington University St. Louis.
​A full agenda for Venturium’25 containing the company names and contact information will be published in the coming weeks. The event will be split into two sessions that run in sequence: Physical Sciences & Life Sciences.
​Timing of event:

​11:30-11:45 | Meet the Academic Instituions Powering Venturium’25
​11:45-12:35 | Physical Sciences Showcase
​12:35-12:45 | Break
​12:45-2:25 | Life Sciences Showcase
​2:25-2:30 | Closing Remarks

​Join us to have the opportunity to discover new ventures, form strategic partnerships, and contribute to the growth of these companies. This event is a valuable platform for networking, learning, and fostering meaningful collaborations.
Register for the event.

Lab to Impact: Intellectual Property Module - Navigating AI-Assisted Innovation: Best Practices for Academic Researchers
2025-05-22 12:00 - 13:00 (America/New_York)
Join the Center for Technology Licensing for a virtual session focused on the practical implications of integrating artificial intelligence (AI) tools into academic research and innovation.
As AI becomes an integral part of research methodologies, it is essential for researchers to understand how to properly document and manage AI’s role in the invention process, ensuring intellectual property (IP) rights are protected.
This session will provide valuable guidance on how to navigate the evolving landscape of AI-assisted research, covering key topics such as:

Strategic approaches to incorporating AI tools in your research workflow
Best practices for documenting AI assistance during invention conception and development
Practical guidelines for maintaining transparent records of AI interactions (prompts and outputs)
Protecting IP potential while leveraging AI capabilities
Understanding the concept of hybrid inventorship in the AI era

Guest speaker:

David Sanker: Founder of Sanker IP
David will provide actionable insights and practical frameworks for researchers looking to optimize their use of AI while safeguarding their intellectual property interests.

Hosted by Martin Teschl, Director of Business Development and Licensing at CTL.
Whether you’re considering a new idea, commercialization, or actively developing a technology, this event offers valuable perspectives on turning promising research into market-ready solutions.

Lab to Impact: Healthcare Module - From Bench to Market: Navigating the Complex Landscape of Drug Commercialization
2025-06-04 12:00 - 13:00 (America/New_York)
Join the Center for Technology Licensing for a dynamic panel on the real-world path from innovation to therapeutic impact.
Industry leaders and biotech entrepreneurs, including Weill Cornell inventors and founders of licensed startup Convergent Therapeutics, will share an insightful discussion on navigating the path from the laboratory to the patient in the drug development space. Whether you’re considering commercialization or actively developing potential new drugs, this panel offers valuable perspectives on turning promising research into new therapies.
Our expert panelists will share practical insights from every stage of the process—from discovery and development, preclinical research, and clinical trials to FDA review and post-market safety monitoring. You’ll gain a better understanding of how regulatory strategy and market access shape the journey, and how successful teams overcome common barriers to bring therapeutics to market.
What to expect:

Key insights into regulatory and market access strategy
Lessons from successful therapeutic launches
Real-world examples of collaboration and adaptation
Expert perspectives across the full drug development lifecycle

Guest speakers:

Alexander Brown, COO of Convergent Therapeutics
Dr. Neil Bander, CSO, Co-Founder of Convergent Therapeutics
Dr. Philip Kantoff, CEO, Co-Founder of Convergent Therapeutics
Dr. Scott Tagawa, Professor of Medicine in Urology at Weill Cornell Medicine

Hosted by Brian Kelly, Director of Technology Licensing, CTL at Weill Cornell Medicine
Whether you’re considering a new idea, commercialization, or actively developing a technology, this event offers valuable perspectives on turning promising research into market-ready solutions.

Cornell Innovation and Venture Advisor (CIVA) Roundtable
2025-09-09 12:00 - 13:00 (America/New_York)
Are you a Cornell inventor seeking expert industry feedback? Connect with us to become a featured presenter at an upcoming session.
Featured Cornell innovators:

Professor, Shaoyi Jiang, Meinig School of Biomedical Engineering
Aaron Pempel, CEO, MAV Unlimited, Inc. Presenting on MAV’s showcase of Robert Shepard’s work on volumetric manufacturing in 3D printing.

For more information on CIVA and research presenters: Click here

Lab to Impact: Understanding the Technology Commercialization Process
2025-09-15 12:00 - 13:00 (America/New_York)
Join the leadership at CTL for the first series, where we focus on intellectual property and guide you through the essential steps of the technology commercialization process. You will gain insights into the end-to-end process, from initial invention disclosure to IP protection, licensing, and ultimately, commercialization. Learn how CTL’s support can help you maximize the impact of your research by successfully navigating the complexities of the commercialization journey.
Register here.

Advancing Women's Health
2025-09-26 11:30 - 13:00 (America/New_York)
Join this special women’s health webinar spotlighting exciting new research at Weill Cornell Medicine. Dr. Zhen Zhao, Professor of Clinical Pathology and Laboratory Medicine, will present her idea for an AI-based clinical decision support tool for predicting the risk of pre-eclampsia.
Following this scientific presentation, we’ll be sitting down with the authors of “Unlocking Investment for Women’s Health”, Dr. Misti Ushio, Managing Partner, Digitalis Ventures, and Ipsita Smolinski, Founder & General Partner, Capitol Street, to explore today’s funding landscape and discuss how investors, government, industry and advocacy groups can work together to accelerate innovations in women’s health.
Don’t miss this opportunity to hear fresh perspectives and novel solutions that can have a significant impact on the women’s health sector in the near term.
Register here.

Ignite Innovation Acceleration Fall 2025 Information Session
2025-10-10 12:00 - 13:00, 2025-10-24 12:00 - 13:00, 2025-11-03 12:00 - 13:00 (America/New_York)
Ignite Innovation Acceleration is a gap funding program offering up to $50,000 to help Cornell research teams advance disclosed inventions toward commercialization. Funding supports work that moves technologies toward licensing, startup formation, or industry partnerships.
Applications are open from September 22 to November 7, 2025.
This session will provide an overview of:

Program goals and funding scope

Application process and timeline

Eligibility and selection criteria

How this program fits into the Ignite: Lab to Market funding series

Register here.

Lab to Impact: From Idea to Prototyping and Design in Medical Devices
2025-10-29 12:00 - 13:00 (America/New_York)
Prototyping is a critical step in translating medical device concepts into real-world solutions. Whether you’re working in a university lab, building a startup, or managing development inside a large company, understanding how to prototype effectively can reduce risk, save time, and guide better design decisions.
This one-hour virtual panel will explore the strategic role of prototyping across stages of development, from early testing to scalable production. Panelists will share experiences from both clinical and industry perspectives.
Speakers:

Audrey Beckman – Medical device executive with 35+ years of experience in product design leadership

Mohammed Fouda, MD – Clinician-innovator at Weill Cornell Medicine, developing a novel medical device

Moderator:Donna Rounds, PhD – Associate Director of Business Development and Licensing, CTL at Weill Cornell Medicine
Register for the October 29 panel discussion.
